Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
6.44
-0.02 (-0.31%)
At close: Oct 19, 2026, 4:00 PM EDT
6.44
0.00 (0.00%)
After-hours: Oct 19, 2026, 4:10 PM EDT
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of $138.25 million as of October 19, 2026. Its market cap has increased by 30.90% in one year.
Market Cap
138.25M
Enterprise Value
75.91M
1-Year Change
30.90%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from $45.99M to $138.25M, an increase of 200.58%. That is a compound annual growth rate of 23.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 138.25M | 54.82% |
| Dec 31, 2025 | 89.30M | -6.65% |
| Dec 31, 2024 | 95.65M | 160.46% |
| Dec 29, 2023 | 36.73M | 440.53% |
| Dec 30, 2022 | 6.79M | -73.94% |
| Dec 31, 2021 | 26.07M | -43.31% |
| Aug 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 146.57M |
| NovaBridge Biosciences | 146.16M |
| Molecular Partners AG | 144.13M |
| Adagene | 138.32M |
| Innate Pharma | 137.25M |
| Protara Therapeutics | 137.10M |
| Jyong Biotech | 136.59M |
| Codexis | 135.79M |